000 | 01141 a2200313 4500 | ||
---|---|---|---|
005 | 20250514212411.0 | ||
264 | 0 | _c20050203 | |
008 | 200502s 0 0 eng d | ||
022 | _a0021-5155 | ||
024 | 7 |
_a10.1007/s10384-004-0110-y _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGrierson, Ian | |
245 | 0 | 0 |
_aLatanoprost and pigmentation. _h[electronic resource] |
260 |
_bJapanese journal of ophthalmology _c |
||
300 |
_a602-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntihypertensive Agents _xadverse effects |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIris _xdrug effects |
650 | 0 | 4 |
_aIris Diseases _xchemically induced |
650 | 0 | 4 | _aLatanoprost |
650 | 0 | 4 |
_aPigmentation Disorders _xchemically induced |
650 | 0 | 4 |
_aProstaglandins F, Synthetic _xadverse effects |
700 | 1 | _aJonsson, Monica | |
700 | 1 | _aCracknell, Kathryn | |
773 | 0 |
_tJapanese journal of ophthalmology _gvol. 48 _gno. 6 _gp. 602-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10384-004-0110-y _zAvailable from publisher's website |
999 |
_c15277084 _d15277084 |